LGR5 and cancer: Previous studies have established high LGR5 transcript levels in CRC and some other cancers (Junttila et al, 2015; Gong et al, 2016) raising the possibility of using α-LGR5 as a cancer biomarker or developing immune-based strategies for therapeutic targeting.